Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin (Q42971655)

12 November 2017

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin (English)

1 reference

12 November 2017

1 reference

Trushar Patel

1

1 reference

12 November 2017

Greg Hruby

2

1 reference

12 November 2017

Ketan Badani

3

1 reference

12 November 2017

Cory Abate-Shen

4

1 reference

12 November 2017

James M McKiernan

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

12 November 2017

1 reference

12 November 2017

76

1 reference

12 November 2017

5

1 reference

12 November 2017

1240-1244

1 reference

Diabetes mellitus and risk of prostate cancer: a meta-analysis

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

A meta-analysis of diabetes mellitus and the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Increased serum insulin associated with increased risk of prostate cancer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Mechanism by which metformin reduces glucose production in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Metformin and reduced risk of cancer in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Prevention of pancreatic cancer induction in hamsters by metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

TOR signaling in growth and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

Saturated fat intake predicts biochemical failure after prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.059

10.1016/J.UROLOGY.2010.03.059

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference